Free Trial
CVE:GSD

Devonian Health Group (GSD) Stock Price, News & Analysis

Devonian Health Group logo
C$0.18 -0.04 (-18.18%)
As of 04/30/2025 10:00 AM Eastern

About Devonian Health Group Stock (CVE:GSD)

Key Stats

Today's Range
C$0.18
C$0.18
50-Day Range
C$0.18
C$0.25
52-Week Range
C$0.08
C$0.35
Volume
7,500 shs
Average Volume
18,857 shs
Market Capitalization
C$26.68 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, completed Phase IIa clinical trial product for the treatment of ulcerative colitis and atopic dermatitis. The company also develops Pantoprazole Magnesium for the treatment of gastric; Cleo-35 for the treatment of hormonal acne in women; and value-added products for dermo-cosmetics. In addition, the company acquires drug and health product licenses; and distributes pharmaceutical products. Devonian Health Group Inc. was incorporated in 2015 and is headquartered in Québec, Canada.

Receive GSD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Devonian Health Group and its competitors with MarketBeat's FREE daily newsletter.

GSD Stock News Headlines

What President Trump’s Executive Order 14154 means for your money
Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a former hedge fund manager who predicted the dotcom crash, the housing crisis, and the 2022 tech stock bloodbath - a little-known executive order from the President's first day in office could spark a paradigm-shift that will likely catch millions of Americans off guard.
Devonian Health Group Reports Cease Trade Order
Devonian Reports Delay of Financial Reporting
See More Headlines

GSD Stock Analysis - Frequently Asked Questions

Devonian Health Group's stock was trading at C$0.16 at the start of the year. Since then, GSD stock has increased by 12.5% and is now trading at C$0.18.
View the best growth stocks for 2025 here
.

Shares of GSD stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
Computer Software
Current Symbol
CVE:GSD
CIK
N/A
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-3,170,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$9.75 million
Cash Flow
C$0.03 per share
Price / Cash Flow
6.10
Book Value
C$0.09 per share
Price / Book
2.00

Miscellaneous

Free Float
N/A
Market Cap
C$26.68 million
Optionable
Not Optionable
Beta
1.28
Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (CVE:GSD) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners